232 related articles for article (PubMed ID: 7069786)
1. Restoration of normal interactions between immune complexes and systemic lupus erythematosus blood cells by normal serum.
Medof ME; Oger JJ; Antel JP; Prince GM
J Clin Lab Immunol; 1982 Feb; 7(2):93-103. PubMed ID: 7069786
[TBL] [Abstract][Full Text] [Related]
2. Ability of complement to release systemic lupus erythematosus immune complexes from cell receptors.
Medof ME; Scarborough D; Miller G
Clin Exp Immunol; 1981 May; 44(2):416-25. PubMed ID: 7307341
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus.
Starkebaum G; Arend WP
J Clin Invest; 1979 Oct; 64(4):902-12. PubMed ID: 479375
[TBL] [Abstract][Full Text] [Related]
4. Impaired monocyte motility in sera from patients with systemic lupus erythematosus.
Sturfelt G; Linder C; Sjöholm AG; Svensson B
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):151-8. PubMed ID: 6880748
[TBL] [Abstract][Full Text] [Related]
5. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.
Anderson CL; Stillman WS
J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484
[TBL] [Abstract][Full Text] [Related]
6. Competition for immune complexes by red cells in human blood.
Medof ME; Oger JJ
J Clin Lab Immunol; 1982 Jan; 7(1):7-13. PubMed ID: 7069779
[TBL] [Abstract][Full Text] [Related]
7. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
8. C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus.
Traustadottir KH; Sigfusson A; Steinsson K; Erlendsson K
J Rheumatol; 2002 Nov; 29(11):2359-66. PubMed ID: 12415592
[TBL] [Abstract][Full Text] [Related]
9. Direct stimulation of neutrophil oxygenation activity by serum from patients with systemic lupus erythematosus: a relationship to disease activity.
Via CS; Allen RC; Welton RC
J Rheumatol; 1984 Dec; 11(6):745-53. PubMed ID: 6520828
[TBL] [Abstract][Full Text] [Related]
10. The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes.
Bányai A; Szabó G; Csongor J; Sonkoly I; Szegedi G
Acta Med Hung; 1985; 42(1-2):51-7. PubMed ID: 4034337
[TBL] [Abstract][Full Text] [Related]
11. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
[TBL] [Abstract][Full Text] [Related]
12. Antibody and immune complexes induce tissue factor production by human endothelial cells.
Tannenbaum SH; Finko R; Cines DB
J Immunol; 1986 Sep; 137(5):1532-7. PubMed ID: 3745915
[TBL] [Abstract][Full Text] [Related]
13. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
14. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
Horgan C; Burge J; Crawford L; Taylor RP
J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
[TBL] [Abstract][Full Text] [Related]
15. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice.
Cruse JM; Lewis RE; Dilioglou S
Exp Mol Pathol; 2000 Dec; 69(3):211-22. PubMed ID: 11115362
[TBL] [Abstract][Full Text] [Related]
16. Failure to detect circulating DNA--anti-DNA complexes by four radioimmunological methods in patients with systemic lupus erythematosus.
Izui S; Lambert PH; Miescher PA
Clin Exp Immunol; 1977 Dec; 30(3):384-92. PubMed ID: 606451
[TBL] [Abstract][Full Text] [Related]
17. Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization.
Salmon JE; Kimberly RP; Gibofsky A; Fotino M
J Immunol; 1984 Nov; 133(5):2525-31. PubMed ID: 6481162
[TBL] [Abstract][Full Text] [Related]
18. A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).
Ng YC; Peters DK; Cederholm-Williams SA; Walport MJ
Clin Exp Immunol; 1987 Jul; 69(1):89-97. PubMed ID: 3115654
[TBL] [Abstract][Full Text] [Related]
19. Solubilization of immune complexes and inhibition of immune precipitation in SLE sera.
Balestrieri G; Pagani D; Tincani A
J Clin Lab Immunol; 1983 Nov; 12(3):147-50. PubMed ID: 6663608
[TBL] [Abstract][Full Text] [Related]
20. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ
J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
